Lumexa Imaging Holdings financials
$10.26+1.13%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 |
|---|---|---|
| Revenue | $264.2M | $252.5M |
| Gross profit | $38.9M | $34.8M |
| Gross margin | 14.7% | 13.8% |
| Operating income | $4.4M | $4.5M |
| Net income | $2.7M | $1.7M |
| Net margin | 1.0% | 0.7% |
| Diluted EPS | $0.03 | $0.02 |
| EBITDA | $14.5M | $14.4M |
| Operating cash flow | $32.8M | $2.9M |
| Free cash flow | $23.1M | -$2.4M |
| Diluted shares | 96.0M | 96.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 |
|---|---|---|---|
| Cash & equivalents | $69.7M | $51.2M | $58.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 |
| Total debt | $889.9M | $882.3M | $877.0M |
| Total assets | $1.81B | $1.76B | $1.76B |
| Total liabilities | $1.19B | $1.16B | $1.18B |
| Shareholders' equity | $615.1M | $599.6M | $586.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology